Cargando…
Unexplained abdominal pain as a driver for inappropriate therapeutics: an audit on the use of intravenous proton pump inhibitors
Background. Proton pump inhibitors (PPIs) are currently the most effective agents for acid-related disorders. However, studies show that 25–75% of patients receiving intravenous PPIs had no appropriate justification, indicating high rates of inappropriate prescribing. Objective. To examine the appro...
Autores principales: | Lai, Pauline Siew Mei, Wong, Yin Yen, Low, Yong Chia, Lau, Hui Ling, Chin, Kin-Fah, Mahadeva, Sanjiv |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4081131/ https://www.ncbi.nlm.nih.gov/pubmed/25024919 http://dx.doi.org/10.7717/peerj.451 |
Ejemplares similares
-
Influence of proton pump inhibitor use on clinical outcomes of patients with inflammatory bowel disease
por: Choden, Tenzin, et al.
Publicado: (2023) -
Improving clinical outcomes of Barrett’s esophagus with high dose proton pump inhibitors and cryoablation
por: Snady, Harry
Publicado: (2023) -
Evolution of proton pump inhibitor prescribing from 2017 to 2021 at 14 secondary and tertiary hospitals in China:a multicentre cross-sectional study
por: Zeng, Min, et al.
Publicado: (2023) -
The prospective multiple-centre randomized controlled clinical study of high-dose amoxicillin-proton pump inhibitor dual therapy for H. pylori infection in Sichuan areas
por: Shen, Cheng, et al.
Publicado: (2022) -
Is administration of proton pump inhibitors in functional dyspepsia worth the risk of developing gastric cancer: a Markov model to bridge the gap between scientific evidence and clinical practice
por: Broide, Efrat, et al.
Publicado: (2020)